Elizabeth A. Mily's Insider Trades & SAST Disclosures
Elizabeth A. Mily's most recent trade in Solventum Corp was a trade of 3,564 Restricted Stock Units done . Disclosure was reported to the exchange on May 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Elizabeth A. Mily.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solventum Corp | Elizabeth A. Mily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 3,564 | 3,564 | - | - | Restricted Stock Units | |
| Solventum Corp | Elizabeth A. Mily | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,980 | 5,544 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 3,662 | 34,058 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 3,662 | 3,663 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 2,684 | 35,873 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2023 | 2,684 | 2,685 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.31 per share. | 01 Apr 2023 | 2,059 | 33,189 (0%) | 0% | 69.3 | 142,709 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 01 Apr 2023 | 1,190 | 35,248 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.31 per share. | 01 Apr 2023 | 1,139 | 34,734 (0%) | 0% | 69.3 | 78,944 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 21,973 | 38,173 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 21,973 | 0 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 21,956 | 21,956 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 14,637 | 14,637 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.71 per share. | 10 Mar 2023 | 10,460 | 30,396 (0%) | 0% | 65.7 | 687,327 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 4,005 | 15,347 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 4,005 | 8,012 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,658 | 17,684 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2023 | 3,658 | 10,976 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 10 Mar 2023 | 2,683 | 40,856 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.71 per share. | 10 Mar 2023 | 1,978 | 14,026 (0%) | 0% | 65.7 | 129,974 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.71 per share. | 10 Mar 2023 | 1,602 | 16,200 (0%) | 0% | 65.7 | 105,267 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 10 Mar 2023 | 657 | 16,004 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 10 Mar 2023 | 118 | 17,802 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 3,662 | 10,482 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 3,662 | 7,325 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,685 | 5,369 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 2,685 | 12,481 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.82 per share. | 01 Apr 2022 | 2,194 | 9,796 (0%) | 0% | 73.8 | 161,961 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 01 Apr 2022 | 1,508 | 11,990 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.82 per share. | 01 Apr 2022 | 1,139 | 11,342 (0%) | 0% | 73.8 | 84,081 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 21,952 | 21,952 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2022 | 14,634 | 14,634 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 4,005 | 8,246 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 4,005 | 12,017 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.42 per share. | 10 Mar 2022 | 1,875 | 6,820 (0%) | 0% | 68.4 | 128,288 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 10 Mar 2022 | 449 | 8,695 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 3,662 | 10,987 | - | - | Market Share Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 3,662 | 3,662 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 2,684 | 5,380 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 2,684 | 8,054 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.93 per share. | 01 Apr 2021 | 1,813 | 2,696 (0%) | 0% | 62.9 | 114,092 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.93 per share. | 01 Apr 2021 | 1,139 | 4,241 (0%) | 0% | 62.9 | 71,677 | Common Stock, $0.10 par value |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Other type of transaction at price $ 0.00 per share. | 01 Apr 2021 | 847 | 4,509 (0%) | 0% | 0 | Common Stock, $0.10 par value | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 24,032 | 24,032 | - | - | Performance Shares | |
| Bristol-Myers Squibb Co. | Elizabeth A. Mily | EVP, Strategy & BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2021 | 16,022 | 16,022 | - | - | Market Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges